SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Reign Sapphire Corp – IPO: ‘S-1’ on 5/27/15 – EX-23.2

On:  Wednesday, 5/27/15, at 4:57pm ET   ·   Accession #:  1615774-15-1269   ·   File #:  333-204486

Previous ‘S-1’:  None   ·   Next:  ‘S-1/A’ on 8/18/15   ·   Latest:  ‘S-1/A’ on 4/10/24   ·   22 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/27/15  Reign Sapphire Corp               S-1                   10:3.4M                                   S2 Filings LLC/FA

Initial Public Offering (IPO):  Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML   2.33M 
 2: EX-3.1      Articles of Incorporation/Organization or By-Laws   HTML     18K 
 3: EX-3.2      Articles of Incorporation/Organization or By-Laws   HTML     75K 
 4: EX-10.1     Material Contract                                   HTML     67K 
 5: EX-10.2     Material Contract                                   HTML     62K 
 6: EX-10.3     Material Contract                                   HTML     44K 
 7: EX-10.4     Material Contract                                   HTML     90K 
 8: EX-10.5     Material Contract                                   HTML     90K 
 9: EX-23.2     Consent of Experts or Counsel                       HTML      6K 
10: EX-99.1     Miscellaneous Exhibit                               HTML     15K 


EX-23.2   —   Consent of Experts or Counsel


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Exhibit 23.2

 

May 26, 2015

 

To the Board of Directors and Stockholders of

Reign Sapphire Corporation

 

We hereby consent to the use in the Prospectus constituting a part of this Registration Statement on Form S-1 (No. XXX-XXXXXX) of our report dated May 26, 2015, relating to the financial statements of Reign Sapphire Corporation (which report expresses an unqualified opinion on the financial statements and includes an explanatory paragraph referring to the Company’s ability to continue as a going concern) for the year ended December 31, 2014 and the period from May 31, 2013 (Inception) through December 31, 2013, which are contained in that Prospectus, which is contained in Part II of this Registration Statement on Form S-1 (No. XXX-XXXXXX).

 

We also consent to the reference to us under the caption “Interests of Named Experts and Counsel” in the Prospectus. 

 

/s/ Hartley Moore Accountancy Corporation

 

HARTLEY MOORE ACCOUNTANCY CORPORATION

May 26, 2015

Irvine, CA

 

 

 

 


Dates Referenced Herein

This ‘S-1’ Filing    Date    Other Filings
Filed on:5/27/15None on these Dates
5/26/15
12/31/14
12/31/13
5/31/13
 List all Filings 


22 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/10/24  Sigyn Therapeutics, Inc.          S-1/A                 68:29M                                    M2 Compliance LLC/FA
 2/20/24  Sigyn Therapeutics, Inc.          10-K       12/31/23   68:8.1M                                   M2 Compliance LLC/FA
 9/22/23  Sigyn Therapeutics, Inc.          S-1/A                 66:13M                                    M2 Compliance LLC/FA
 5/10/23  Sigyn Therapeutics, Inc.          S-1/A                 64:8.6M                                   M2 Compliance LLC/FA
 3/31/23  Sigyn Therapeutics, Inc.          10-K       12/31/22   67:7.8M                                   M2 Compliance LLC/FA
 2/28/23  Sigyn Therapeutics, Inc.          S-1/A                 26:7.5M                                   M2 Compliance LLC/FA
12/23/22  Sigyn Therapeutics, Inc.          S-1/A                 67:36M                                    M2 Compliance LLC/FA
11/14/22  Sigyn Therapeutics, Inc.          10-Q        9/30/22   61:6.7M                                   M2 Compliance LLC/FA
11/07/22  Sigyn Therapeutics, Inc.          S-1/A                 74:208M                                   M2 Compliance LLC/FA
 8/30/22  Sigyn Therapeutics, Inc.          S-1/A       8/29/22   76:103M                                   M2 Compliance LLC/FA
 8/15/22  Sigyn Therapeutics, Inc.          10-Q        6/30/22   60:6.8M                                   M2 Compliance LLC/FA
 6/23/22  Sigyn Therapeutics, Inc.          S-1                   63:7.7M                                   M2 Compliance LLC/FA
 5/13/22  Sigyn Therapeutics, Inc.          10-Q        3/31/22   58:3.8M                                   M2 Compliance LLC/FA
 3/21/22  Sigyn Therapeutics, Inc.          10-K       12/31/21   64:5.6M                                   M2 Compliance LLC/FA
11/12/21  Sigyn Therapeutics, Inc.          10-Q        9/30/21   57:5M                                     M2 Compliance LLC/FA
 8/16/21  Sigyn Therapeutics, Inc.          10-Q        6/30/21   57:4.2M                                   M2 Compliance LLC/FA
 5/17/21  Sigyn Therapeutics, Inc.          10-Q        3/31/21   51:2.9M                                   M2 Compliance LLC/FA
 4/06/21  Sigyn Therapeutics, Inc.          10-K       12/31/20   55:3M                                     M2 Compliance LLC/FA
10/21/15  SEC                               UPLOAD10/06/17    1:138K Sigyn Therapeutics, Inc.
10/01/15  SEC                               UPLOAD10/06/17    1:140K Sigyn Therapeutics, Inc.
 9/10/15  SEC                               UPLOAD10/06/17    1:156K Sigyn Therapeutics, Inc.
 6/24/15  SEC                               UPLOAD10/06/17    1:206K Sigyn Therapeutics, Inc.
Top
Filing Submission 0001615774-15-001269   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 9:49:19.2pm ET